Dovato 50 mg

Dovato 50 mg tablets contain dolutegravir, an antiretroviral medication used in HIV treatment. This combination therapy helps manage HIV infection by reducing viral load.

Dovato 50 mg tablets are primarily used in the treatment of HIV-1 infection. This medication is part of a combination therapy that works by reducing the amount of HIV in the body, helping to control the infection. It is often prescribed for individuals who have not previously taken antiretroviral therapy or for those who are switching from other regimens. The active ingredient, dolutegravir, is an integrase inhibitor that prevents the virus from multiplying.

Common effects of Dovato 50 mg tablets may include headache, nausea, and diarrhea. Some individuals might experience fatigue or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Dovato 50 mg tablets should be handled with care. Store them at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Always follow the prescribed dosage and administration instructions provided by your healthcare provider.

Dovato 50 mg tablets may interact with certain medications, including antacids, antibiotics, and other antiretroviral drugs. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may exacerbate some side effects.